Dollars

SPDR S&P Biotech ETF receives settlement payment

State Street Global Advisors’ SPDR S&P Biotech ETF has received a payment as an authorised claimant from a class action settlement related to Dendreon Corp.

The total amount payable to the fund is USD233,312.
 
When the fund calculates its net asset value (NAV) per share on 19 August it is estimated that the fund’s NAV will be impacted by USD0.0311 for each of the existing 7,500,000 shares.

Further reading



Upcoming events

57 min 56 sec from now - Amsterdam
1 day 57 min from now - London
1 week 1 day from now - London
1 week 1 day from now - London
1 week 1 day from now - Cartegena

Upcoming training